CinCor Pharma Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and CinCor Pharma are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CinCor Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, CinCor Pharma is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
CinCor |
CinCor Pharma Relative Risk vs. Return Landscape
If you would invest (100.00) in CinCor Pharma on October 15, 2025 and sell it today you would earn a total of 100.00 from holding CinCor Pharma or generate -100.0% return on investment over 90 days. CinCor Pharma is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than CinCor, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CinCor Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CinCor Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CinCor Pharma, and traders can use it to determine the average amount a CinCor Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CINC |
Based on monthly moving average CinCor Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CinCor Pharma by adding CinCor Pharma to a well-diversified portfolio.
CinCor Pharma Fundamentals Growth
CinCor Stock prices reflect investors' perceptions of the future prospects and financial health of CinCor Pharma, and CinCor Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CinCor Stock performance.
| Return On Equity | -0.27 | |||
| Return On Asset | -0.15 | |||
| Current Valuation | 7.93 M | |||
| Shares Outstanding | 43.76 M | |||
| Price To Book | 1.02 X | |||
| EBITDA | (50.35 M) | |||
| Cash And Equivalents | 294.31 M | |||
| Cash Per Share | 7.80 X | |||
| Book Value Per Share | 11.86 X | |||
| Cash Flow From Operations | (30.85 M) | |||
| Earnings Per Share | (2.01) X | |||
| Total Asset | 141.11 M | |||
Things to note about CinCor Pharma performance evaluation
Checking the ongoing alerts about CinCor Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CinCor Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CinCor Pharma is not yet fully synchronised with the market data | |
| CinCor Pharma has some characteristics of a very speculative penny stock | |
| CinCor Pharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (50.37 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CinCor Pharma currently holds about 294.31 M in cash with (30.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.8. | |
| Over 94.0% of the company shares are held by institutions such as insurance companies |
- Analyzing CinCor Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CinCor Pharma's stock is overvalued or undervalued compared to its peers.
- Examining CinCor Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CinCor Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CinCor Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CinCor Pharma's stock. These opinions can provide insight into CinCor Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in CinCor Stock
If you are still planning to invest in CinCor Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CinCor Pharma's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stocks Directory Find actively traded stocks across global markets |